IL95279A - 4-]ציקלואלקילן-1- )אימידאזוליל או טריאזוליל( מתיל[- בנזוניטרילים ותולדותיהם, תהליכים להכנתם ותכשירי רוקחות המכילים אותם - Google Patents

4-]ציקלואלקילן-1- )אימידאזוליל או טריאזוליל( מתיל[- בנזוניטרילים ותולדותיהם, תהליכים להכנתם ותכשירי רוקחות המכילים אותם

Info

Publication number
IL95279A
IL95279A IL9527990A IL9527990A IL95279A IL 95279 A IL95279 A IL 95279A IL 9527990 A IL9527990 A IL 9527990A IL 9527990 A IL9527990 A IL 9527990A IL 95279 A IL95279 A IL 95279A
Authority
IL
Israel
Prior art keywords
methyl
imidazolyl
benzonitrile
cycloalkylene
triazolyl
Prior art date
Application number
IL9527990A
Other languages
English (en)
Other versions
IL95279A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL95279A0 publication Critical patent/IL95279A0/xx
Publication of IL95279A publication Critical patent/IL95279A/he

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
IL9527990A 1989-08-04 1990-08-03 4-]ציקלואלקילן-1- )אימידאזוליל או טריאזוליל( מתיל[- בנזוניטרילים ותולדותיהם, תהליכים להכנתם ותכשירי רוקחות המכילים אותם IL95279A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3926365A DE3926365A1 (de) 1989-08-04 1989-08-04 Cycloalkylenazole, verfahren zu deren herstellung, pharmazeutische praeparate, die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln

Publications (2)

Publication Number Publication Date
IL95279A0 IL95279A0 (en) 1991-06-30
IL95279A true IL95279A (he) 1995-03-30

Family

ID=6386820

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9527990A IL95279A (he) 1989-08-04 1990-08-03 4-]ציקלואלקילן-1- )אימידאזוליל או טריאזוליל( מתיל[- בנזוניטרילים ותולדותיהם, תהליכים להכנתם ותכשירי רוקחות המכילים אותם

Country Status (19)

Country Link
US (3) US5135937A (he)
EP (1) EP0411735B1 (he)
JP (1) JP3207417B2 (he)
CN (1) CN1024345C (he)
AT (1) ATE122662T1 (he)
AU (1) AU634266B2 (he)
CA (1) CA2022682C (he)
DD (1) DD296917A5 (he)
DE (2) DE3926365A1 (he)
DK (1) DK0411735T3 (he)
ES (1) ES2074530T3 (he)
FI (1) FI920425A0 (he)
HU (2) HU217126B (he)
IE (1) IE902843A1 (he)
IL (1) IL95279A (he)
NO (1) NO301115B1 (he)
PT (1) PT94884B (he)
WO (1) WO1991001975A1 (he)
ZA (1) ZA906150B (he)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352795A (en) * 1986-03-07 1994-10-04 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US5112845A (en) * 1986-03-07 1992-05-12 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
TW224461B (he) * 1990-09-18 1994-06-01 Ciba Geigy Ag
DE4107038A1 (de) * 1991-03-01 1992-09-03 Schering Ag Triheteroarylmethane, verfahren zu deren herstellung, pharmazeutische praeparate die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln
DE4120107A1 (de) * 1991-06-14 1992-12-17 Schering Ag Bicyclisch substituierte vinylimidazole, -triazole und -tetrazole
DE4435368A1 (de) * 1994-09-22 1996-03-28 Schering Ag Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
CA2380940C (en) * 1999-08-13 2013-06-25 Heinrich Wieland Substances and agents for positively influencing collagen
CN101253160A (zh) * 2005-07-06 2008-08-27 西科尔公司 制备来曲唑的改进方法
CN100425621C (zh) * 2006-07-06 2008-10-15 云南大学 甾体咪唑盐类化合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
JPS62149666A (ja) * 1985-12-25 1987-07-03 Shionogi & Co Ltd N−ビニルアゾ−ル類
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles

Also Published As

Publication number Publication date
EP0411735B1 (de) 1995-05-17
US5135937A (en) 1992-08-04
IE902843A1 (en) 1991-02-27
DE59009084D1 (de) 1995-06-22
CN1049157A (zh) 1991-02-13
AU6019490A (en) 1991-02-07
WO1991001975A1 (de) 1991-02-21
JP3207417B2 (ja) 2001-09-10
NO301115B1 (no) 1997-09-15
HUT59911A (en) 1992-07-28
DE3926365A1 (de) 1991-02-07
CN1024345C (zh) 1994-04-27
CA2022682C (en) 1997-01-21
PT94884B (pt) 1997-04-30
NO920432D0 (no) 1992-02-03
HU9200324D0 (en) 1992-04-28
IL95279A0 (en) 1991-06-30
ES2074530T3 (es) 1995-09-16
ATE122662T1 (de) 1995-06-15
ZA906150B (en) 1991-05-29
EP0411735A1 (de) 1991-02-06
FI920425A0 (fi) 1992-01-30
US5411982A (en) 1995-05-02
US5280035A (en) 1994-01-18
NO920432L (no) 1992-02-03
DK0411735T3 (da) 1995-10-16
CA2022682A1 (en) 1991-02-05
AU634266B2 (en) 1993-02-18
PT94884A (pt) 1991-04-18
DD296917A5 (de) 1991-12-19
HU217126B (hu) 1999-11-29
JPH05501104A (ja) 1993-03-04

Similar Documents

Publication Publication Date Title
US4935437A (en) (Substituted aralkyl) heterocyclic compounds
EP0337928A1 (de) N-substituierte Imidazole, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
EP0073663A2 (en) Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
HU194839B (en) Process for production of derivatives of triasole and imidasole and medical preparatives containing such compounds
US4916148A (en) Naphtho(2,1-b) furan derivatives
US5135937A (en) Cycloalkylene azoles and pharmaceutical preparations obtained therefrom
EP0054417A1 (en) Indole thromboxane synthetase inhibitors, processes for their preparation, and pharmaceutical compositions containing them
NO168033B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive triazol-og imidazol-derivater.
AU682947B2 (en) Novel azolyl methyl phenyl derivatives having aromatase inhibitory activity
US4910212A (en) Heterocyclic compounds
NO310237B1 (no) Nye selektive aromatase-inhiberende forbindelser, farmasöytisk preparat og anvendelse av forbindelsene
IE58352B1 (en) Benzocycloalkane derivatives
EP0069513A2 (en) Indole thromboxane synthetase inhibitors, processes for their preparation, and pharmaceutical compositions containing them
US5376669A (en) α-fluoro-α-(1,2,3-triazolyl)-phenylmethyl derivatives useful as aromatase inhibitors
US5344834A (en) Functionalized vinyl azoles and methods of use
IE921936A1 (en) Bicyclic-substituted vinylimidazoles, -triazoles and¹-tetrazoles
CA2105175A1 (en) Triheteroarylmethanes, method for preparing them, pharmaceutical preparations containing them and their use to manufacture drugs
HU209302B (en) Method for producing dihydro-benzo-(b)-thiphenes and pharmaceutical preparatives containing these compounds
JPH07138160A (ja) アゾール誘導体を含有する抗アロマターゼ剤
HUT72299A (en) Novel selective aromatase inhibiting heterocyclic compounds, pharmaceutical compositions containing them and process for preparing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees